...
首页> 外文期刊>American Journal of Physiology >Aryl hydrocarbon receptor and NF-E2-related factor 2 are key regulators of human MRP4 expression.
【24h】

Aryl hydrocarbon receptor and NF-E2-related factor 2 are key regulators of human MRP4 expression.

机译:芳基烃受体和NF-E2相关因子2是人MRP4表达的关键调节因子。

获取原文
获取原文并翻译 | 示例

摘要

Multidrug resistance protein 4 (MRP4; ABCC4) is an ATP binding cassette transporter that facilitates the excretion of bile salt conjugates and other conjugated steroids in hepatocytes and renal proximal tubule epithelium. MRP4/Mrp4 undergoes adaptive upregulation in response to oxidative and cholestatic liver injury in human and animal models of cholestasis. However, the molecular mechanism of this regulation remains to be determined. The aryl hydrocarbon receptor (AhR) and NF-E2-related factor 2 (Nrf2) play important roles in protecting cells from oxidative stress. Here we examine the role of these two nuclear factors in the regulation of the expression of human MRP4. HepG2 cells and human hepatocytes were treated with the AhR and Nrf2 activators, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 3-methylcholanthrene (3-MC), or oltipraz and other nuclear receptor agonists. TCDD, 3-MC, and oltipraz significantly increased MRP4 expression at mRNA and protein levels. Computer program analysis revealed three Xenobiotic response element (XRE) and one Maf response element sites within the first 500 bp of the MRP4 proximal promoter. Luciferase reporter assay detected strong promoter activity (53-fold higher than vector control) in this region. TCDD and 3-MC also induced promoter activity in the reporter assays. Mutation of any of these XRE sites significantly decreased MRP4 promoter activity in reporter assays, although XRE2 demonstrated the strongest effects on both basal and TCDD-inducible activity. EMSA and chromatin immunoprecipitation assays further confirmed that both AhR and Nrf2 bind to the proximal promoter of MRP4. Our findings indicate that AhR and Nrf2 play important roles in regulating MRP4 expression and suggest that agents that activate their activity may be of therapeutic benefit for cholestasis.
机译:多药抗性蛋白4(MRP4; ABCC4)是ATP结合盒转运盒,其促进胆汁盐缀合物和肝细胞中的其他共轭类固醇的排泄和肾近端小管上皮。 MRP4 / MRP4经历适应性上调,以应对胆汁淤积的人和动物模型中的氧化和胆汁淤积肝损伤。然而,该调节的分子机制仍有待确定。芳基烃受体(AHR)和NF-E2相关因子2(NRF2)在保护细胞免受氧化应激中起重要作用。在这里,我们研究这两个核因素在调控人MRP4表达中的作用。用AHR和NRF 2活化剂,2,3,7,8-四氯二氯胺-P-二恶蛋白(TCDD),3-甲基蒽(3-MC)或OltiPRAZ和其他核受体激动剂处理HepG2细胞和人肝细胞。 TCDD,3-MC和OLTIPRAZ显着增加MRP4在mRNA和蛋白质水平下的表达。计算机程序分析显示了MRP4近端启动子的前500bp内的三种异丙酸反应元件(XRE)和一个MAF响应元素位点。荧光素酶报告器测定检测该区域的强启动子活性(比载体对照53倍高)。 TCDD和3-MC还诱导报告分析中的启动子活性。这些XRE位点的突变显着降低了报告分析中的MRP4启动子活性,尽管XRE2对基础和TCDD诱导活性的最强烈作用。 EMSA和染色质免疫沉淀测定进一步证实AHR和NRF2均结合MRP4的近端启动子。我们的研究结果表明,AHR和NRF2在调节MRP4表达方面发挥着重要作用,并表明激活其活性的药剂可能对胆汁淤积产生治疗益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号